MA38292A1 - Composition de diclofenac et ses sels, pour prevenir l'inflammation et la douleur associees au rhumatisme de l'arthrite - Google Patents
Composition de diclofenac et ses sels, pour prevenir l'inflammation et la douleur associees au rhumatisme de l'arthriteInfo
- Publication number
- MA38292A1 MA38292A1 MA38292A MA38292A MA38292A1 MA 38292 A1 MA38292 A1 MA 38292A1 MA 38292 A MA38292 A MA 38292A MA 38292 A MA38292 A MA 38292A MA 38292 A1 MA38292 A1 MA 38292A1
- Authority
- MA
- Morocco
- Prior art keywords
- diclofenac
- composition
- salts
- pain associated
- prevent inflammation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La présente invention concerne une composition comprenant du diclofénac et des sels de celui-ci, le diclofénac ou ses sels étant présents dans une quantité de 25 à 200 mg. La composition est appropriée pour l'administration parentérale à travers une voie intraveineuse, intramusculaire ; également pour une administration orale, dermique, sous-cutanée, cutanée, nasale, par gouttes oculaires, comme suppositoire rectal, par pessaires vaginaux, intra-articulaire et otique. L'invention concerne également des compositions comprenant une combinaison de diclofénac et d'autres médicaments. L'invention concerne en outre un procédé de préparation de ladite composition.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3704MU2012 | 2012-12-28 | ||
PCT/IN2013/000805 WO2014102824A1 (fr) | 2012-12-28 | 2013-12-27 | Composition de diclofénac |
Publications (1)
Publication Number | Publication Date |
---|---|
MA38292A1 true MA38292A1 (fr) | 2017-06-30 |
Family
ID=54198802
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA38292A MA38292A1 (fr) | 2012-12-28 | 2013-12-27 | Composition de diclofenac et ses sels, pour prevenir l'inflammation et la douleur associees au rhumatisme de l'arthrite |
Country Status (25)
Country | Link |
---|---|
US (1) | US20140187635A1 (fr) |
EP (1) | EP2938325B8 (fr) |
JP (1) | JP6117939B2 (fr) |
KR (1) | KR101730284B1 (fr) |
CN (1) | CN104968331A (fr) |
AP (1) | AP2015008534A0 (fr) |
AU (1) | AU2013368849B2 (fr) |
BR (1) | BR112015015699B1 (fr) |
CL (1) | CL2015001869A1 (fr) |
EA (1) | EA035079B1 (fr) |
ES (1) | ES2721400T3 (fr) |
HK (1) | HK1211858A1 (fr) |
HU (1) | HUE045030T2 (fr) |
IL (1) | IL239395A0 (fr) |
MA (1) | MA38292A1 (fr) |
MX (1) | MX365375B (fr) |
MY (1) | MY184886A (fr) |
PE (1) | PE20151208A1 (fr) |
PH (1) | PH12015501479A1 (fr) |
SG (1) | SG11201504577UA (fr) |
SI (1) | SI2938325T1 (fr) |
TR (1) | TR201905806T4 (fr) |
UA (1) | UA114123C2 (fr) |
WO (1) | WO2014102824A1 (fr) |
ZA (1) | ZA201504258B (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101524473B1 (ko) * | 2014-12-22 | 2015-06-02 | 주식회사 한국팜비오 | 주사제 조성물 |
WO2016170401A1 (fr) * | 2015-04-20 | 2016-10-27 | Umedica Laboratories Pvt. Ltd | Nouvelle composition injectable de diclofénac sodique |
US11110073B2 (en) | 2017-03-24 | 2021-09-07 | Cadila Healthcare Limited | Storage stable aqueous injectable solution comprising diclofenac |
GB201720992D0 (en) * | 2017-12-15 | 2018-01-31 | Hooper Mark | A medical use |
GR1009729B (el) * | 2018-08-02 | 2020-05-15 | Win Medica Φαρμακευτικη Ανωνυμη Εταιρεια | Σταθερος ενεσιμος συνδυασμος |
KR20210093256A (ko) * | 2018-11-16 | 2021-07-27 | 세이가가쿠 고교 가부시키가이샤 | 의약 조성물 |
US20220280463A1 (en) | 2019-09-09 | 2022-09-08 | Ftf Pharma Private Limited | Pharmaceutical formulations comprising diclofenac |
US11707443B2 (en) | 2019-09-26 | 2023-07-25 | Rk Pharma Inc. | Storage stable aqueous parenteral solutions comprising diclofenac |
TW202140062A (zh) * | 2020-02-18 | 2021-11-01 | 丹麥商諾佛 儂迪克股份有限公司 | Glp-1組成物及其用途 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3324193A1 (de) | 1983-07-05 | 1985-01-17 | Troponwerke Gmbh & Co Kg | Depot-antiphlogistika |
DE3446873A1 (de) | 1984-12-21 | 1986-07-10 | Merckle Gmbh | Fluessige diclofenac-zubereitungen |
US5283067A (en) * | 1987-01-30 | 1994-02-01 | Ciba-Geigy Corporation | Parenteral suspensions |
EP0661050A1 (fr) * | 1991-07-04 | 1995-07-05 | Taisho Pharmaceutical Co. Ltd | Analgesique |
US5389681A (en) | 1992-10-22 | 1995-02-14 | Ciba-Geigy Corporation | Parenteral solutions for diclofenac salts |
ZA949182B (en) | 1993-12-02 | 1995-07-26 | South African Druggists Ltd | Pharmaceutical composition |
JP4542743B2 (ja) * | 2002-12-26 | 2010-09-15 | Kdl株式会社 | ピリドン誘導体の溶液状医薬組成物 |
AU2004226323A1 (en) * | 2003-03-26 | 2004-10-14 | Becton, Dickinson And Company | Use of benzyl alcohol, and other phenolic preservatives to reduce pain during intradermal injection |
WO2005027977A2 (fr) | 2003-09-22 | 2005-03-31 | Agis Industries (1983) Ltd. | Compositions de diclofenac destinees au traitement d'affections cutanees |
US20050238674A1 (en) | 2004-03-10 | 2005-10-27 | Shimoda Biotech (Pty) Ltd. | Stable injectable compositions |
US20050214230A1 (en) * | 2004-03-23 | 2005-09-29 | J. B. Chemicals & Pharmaceuticals Ltd. | Novel stomatological gel |
US8809393B2 (en) * | 2005-02-01 | 2014-08-19 | Troikaa Pharmaceuticals Ltd | Injectable preparations of diclofenac and its pharmaceutically acceptable salts |
KR20080016689A (ko) * | 2005-05-27 | 2008-02-21 | 파나세아 바이오테크 리미티드 | 약물주사가 가능한 새로운 형태의 조성물 및 이러한조성물을 위한 조제방법 |
EA201100863A1 (ru) | 2008-11-28 | 2011-12-30 | Эдванс Холдингз Лимитед | Фармацевтическая композиция, включающая диклофенак и сложный эфир гидроксижирной кислоты и полиоксиалкилена |
-
2013
- 2013-12-24 US US14/140,109 patent/US20140187635A1/en not_active Abandoned
- 2013-12-27 WO PCT/IN2013/000805 patent/WO2014102824A1/fr active Application Filing
- 2013-12-27 CN CN201380068194.2A patent/CN104968331A/zh active Pending
- 2013-12-27 MY MYPI2015001527A patent/MY184886A/en unknown
- 2013-12-27 AU AU2013368849A patent/AU2013368849B2/en active Active
- 2013-12-27 TR TR2019/05806T patent/TR201905806T4/tr unknown
- 2013-12-27 PE PE2015001194A patent/PE20151208A1/es not_active Application Discontinuation
- 2013-12-27 SG SG11201504577UA patent/SG11201504577UA/en unknown
- 2013-12-27 EP EP13830158.5A patent/EP2938325B8/fr active Active
- 2013-12-27 JP JP2015550212A patent/JP6117939B2/ja active Active
- 2013-12-27 AP AP2015008534A patent/AP2015008534A0/xx unknown
- 2013-12-27 MA MA38292A patent/MA38292A1/fr unknown
- 2013-12-27 BR BR112015015699-1A patent/BR112015015699B1/pt active IP Right Grant
- 2013-12-27 EA EA201591230A patent/EA035079B1/ru not_active IP Right Cessation
- 2013-12-27 MX MX2015008369A patent/MX365375B/es active IP Right Grant
- 2013-12-27 ES ES13830158T patent/ES2721400T3/es active Active
- 2013-12-27 HU HUE13830158A patent/HUE045030T2/hu unknown
- 2013-12-27 UA UAA201506371A patent/UA114123C2/uk unknown
- 2013-12-27 SI SI201331424T patent/SI2938325T1/sl unknown
- 2013-12-27 KR KR1020157017781A patent/KR101730284B1/ko active IP Right Grant
-
2015
- 2015-06-11 ZA ZA2015/04258A patent/ZA201504258B/en unknown
- 2015-06-14 IL IL239395A patent/IL239395A0/en unknown
- 2015-06-26 CL CL2015001869A patent/CL2015001869A1/es unknown
- 2015-06-26 PH PH12015501479A patent/PH12015501479A1/en unknown
- 2015-12-30 HK HK15112837.5A patent/HK1211858A1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA38292A1 (fr) | Composition de diclofenac et ses sels, pour prevenir l'inflammation et la douleur associees au rhumatisme de l'arthrite | |
MA46452B1 (fr) | Composés de benzo[b]thiophéne en tant qu'agonistes de sting | |
MA45598B1 (fr) | Stéroles 24-hydroxylés substitués en position 11 pour le traitement des maladies liées au récepteur nmda | |
BR112013027667A2 (pt) | limitador para um dispositivo de dispensação | |
MA30291B1 (fr) | Derives de l'azolopyridin-3-one en tant qu'inhibiteurs de la lipase endotheliale | |
MA34299B1 (fr) | Dérivés d'aminopyrimidine au titre de modulateurs de lrrk2 | |
EA201291108A1 (ru) | Фармацевтические композиции в виде эмульсии с низким содержанием масла, содержащие прогестоген | |
EA200970047A1 (ru) | Водные суспензии тмс278 | |
MA38576A1 (fr) | Formulations de colchicine à libération prolongée et procédés d'utilisation de ces dernières | |
AR078304A1 (es) | Agonistas receptores de oxitocina | |
MX2013002422A (es) | Sales de lorcaserina con acidos opticamente activos. | |
MA33533B1 (fr) | Compositions pharmaceutiques pour le traitement du cancer et d'autres maladies ou troubles | |
MA35411B1 (fr) | Nouvelle composition thérapeutique contenant de l'apomorphine comme principe actif | |
MA34489B1 (fr) | Agonistes du récepteur a1 à l'adénosine destinés au traitement du glaucome et de l'hypertension oculaire | |
BR112015021425A2 (pt) | composições lubrificantes que incluem copolímeros de alfa-olefina | |
IN2012DN01251A (fr) | ||
MA34291B1 (fr) | Compositions et méthodes de diagnostic et de traitement d'une tumeur | |
TN2015000176A1 (fr) | Pastille medicamenteuse a base d'ibuprofene sodique dihydrate | |
MA53898B1 (fr) | Dérivés de 4-pyrazin-2-ylméthyl-morpholine et leur utilisation comme médicament | |
WO2019152776A8 (fr) | Compositions et dispositifs pour l'administration systémique d'uridine | |
MA33938B1 (fr) | 5-alcynyl-pyrimidines | |
EA202090287A1 (ru) | Составы пролонгированного действия | |
Studt | Heparin-induced thrombocytopenia?: case report | |
ATE522537T1 (de) | (e)-n-ä3-ä1-(8-fluor-11h-10-oxa-1-aza-dibenzo-ä , dü-cyclohepten-5-yliden)-propylü-phenylü- methylsulfon-amid als glucocorticoid- rezeptormodulator zur behandlung rheumatoider arthritis | |
AU2011100789A4 (en) | The use of emu oil as an anti-inflammatory in cases of auto-immune hypothyroidism |